invoX

invoX Pharma is a wholly-owned subsidiary of Sino Biopharmaceutical Limited, a top 50 global pharmaceutical company. Our primary goal is to become a fully integrated biopharmaceutical company with a continuous pipeline of innovative products to meet unmet healthcare needs worldwide. Through multiple acquisitions and investments, we are building a scalable platform to establish a promising portfolio of clinical and preclinical stage drug candidates, which we believe will improve people's lives through innovative medicines in some of our key therapeutic areas, including oncology and respiratory.